Pharma Marketing Faces a Character-Count Conundrum

this_boat_is_real writes "There's growing concern over how pharmaceutical companies use social media and the Internet to market their products. Last November, the US Food and Drug Administration held a hearing on the topic, and many were worried over how marketing mediums such as Twitter — which has a 140-character limit on text — can sufficiently disclose drug risks." Here's the FDA's announcement about last year's hearings, which includes links to an archive of presentations as well as a video record of the meeting.

Comments

Re:Sure, let's solve those disclosure requirements

[jx100]

By telling all the doctors that some drug exists, who will then tell the people when they go to see them about the new giant growth in their neck.